Seaport Therapeutics, Inc. (SPTX)
Last updated: 2026-10-20 16:53:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Seaport Therapeutics, Inc. (SPTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $18.83, with a market capitalization of $954.45M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.85 to $28.38. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$954.45M | |
$17.98 | |
$28.38 | |
$14.85 | |
$17.79 | |
39.05K | |
191.05K | |
-- | |
$28.38 | |
$14.85 | |
-- | |
-- |
Seaport Therapeutics, Inc. (SPTX) Stock Price Today
Seaport Therapeutics, Inc. (SPTX) is currently trading at $18.83 as of 2026-10-20 16:51:00, up 5.85% ($1.04) from the previous close of $17.79
During today's regular trading session, SPTX has traded between $14.85 and $28.38, with a trading volume of 39.05K shares. The current price is near the lower end of today's range.
Seaport Therapeutics, Inc. (SPTX) 7-Day Stock Price Change
Over the past seven days, Seaport Therapeutics, Inc. (SPTX) moved from $18.15 to $18.83, representing a gain of 3.75% ($0.68).
The stock traded between $15.79 and $19.62 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 175.46 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
SPTX 52-Week Price Position
Position in Range: 29.4%
SPTX is currently trading at $18.83, placing it 29.4% of the way from its 52-week low of $14.85 to its 52-week high of $28.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Seaport Therapeutics, Inc. (SPTX)?
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
Seaport Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
| Company Website |
How to Buy Seaport Therapeutics, Inc. (SPTX) Stock on MEXC
Eligible investors can buy real shares of Seaport Therapeutics, Inc. (SPTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Seaport Therapeutics, Inc. (SPTX) stock price today?
2.Is SPTX stock going up or down today?
3.What is SPTX pre-market price?
4.What is SPTX after-hours price?
5.Is SPTX stock trading now?
6.Where does SPTX sit relative to its 52-week high and low?
7.What sector is Seaport Therapeutics, Inc. in?
8.What is Seaport Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is SPTX valued in terms of P/E ratio and EPS?
10.Does Seaport Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
SPTX Stock Calculator
Estimate the value between SPTX shares and USD.
SPTX Shares to USD
1.00 SPTX shares = 18.83 USD
Calculations are estimates based on the latest available price and are for reference only.


